Yali Friedman, Ph.D., is founder of thinkBiotech and chief editor
and publisher of the Journal of Commercial
Biotechnology. His book, Building
Biotechnology, is used as a course text in dozens of
biotechnology programs. His other books include
Best Practices in Biotechnology Education and Best
Practices in Biotechnology Business Development. He is also a member
of the board of directors of AmericasHealth, serves on the
science advisory
board of Chakra Biotech,
an associate of the World Technology Network, and
also serves as a judge for the Biotech Humanitarian
Award and the Maryland Incubator Company of the Year Award.
Dr. Friedman has strong exposure to leading issues in international biotechnology. He is lead editorial consultant for Scientific American's worldVIEW, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and for individual countries such as Japan, Canada, Germany, the Philippines, and Turkey.
Dr. Friedman teaches biotechnology management at the National Institutes of Health and regularly guest-lectures for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.
Dr. Friedman has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times company, which was named to Forbes "Best of the Web" list. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.
Featured in:
